Please use this identifier to cite or link to this item:
Production of the Bacteriocin Antibiotic Thuricin CD
|2015-12-ms-holjencin_r.pdf||Version for non-UH users. Copying/Printing is not permitted||12.76 MB||Adobe PDF||View/Open|
|2015-12-ms-holjencin_uh.pdf||For UH users only||12.75 MB||Adobe PDF||View/Open|
|Title:||Production of the Bacteriocin Antibiotic Thuricin CD|
|Issue Date:||Dec 2015|
|Publisher:||[Honolulu] : [University of Hawaii at Manoa], [December 2015]|
|Abstract:||Bacteriocins are ribosomally produced peptide antibiotics produced by bacteria as highly effective antimicrobial natural products. Many bacteriocins are thought to function by selective insertion of multimers into the cell membrane, generating unregulated ion pores that ultimately trigger cell lysis. Bacteriocins often contain stabilizing post-translational modifications including N- and C-terminal additions, epimerized D-amino acids, chemically modified amino acids, and disulfide and thioether crosslinks.|
Thuricin CD is a two-component antimicrobial consisting of peptides, Trnα and Trnβ, produced by Bacillus thuringiensis, that specifically targets the bacterium Clostridium difficile. Each peptide contains three thioether crosslinks in which cysteine residues are chemically bonded to the α-carbon of distal amino acid residues; the resulting compact structure is highly resistant to proteolysis. The thioether crosslinks are proposed to be introduced by the radical SAM enzymes TrnC and/or TrnD. In this work, we develop a fusion protein strategy for producing the propeptides TrnA and TrnB and further demonstrate that TrnC alone is capable of introducing two of the thioether crosslinks. The successful in vitro production of thuricin CD could provide a potential lead for novel antimicrobials targeting C. difficile infections.
|Description:||M.S. University of Hawaii at Manoa 2015.|
Includes bibliographical references.
|Appears in Collections:||M.S. - Chemistry|
Please contact firstname.lastname@example.org if you need this content in an ADA compliant alternative format.
Items in ScholarSpace are protected by copyright, with all rights reserved, unless otherwise indicated.